Ads
related to: asthma inhaler prices
Search results
Results from the WOW.Com Content Network
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.
(Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...
Prices are rising sharply on many asthma inhalers just in time for spring allergy season and some insurance companies are not covering the higher costs, and many patients cannot afford the high ...
An inhaler (puffer, asthma pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications.
The cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and Trelegy Ellipta, and would apply to patients ...
[2] [3] [4] It is used in the management of asthma and chronic obstructive pulmonary disease (COPD). [4] It is used by inhaling the medication into the lungs. [4] Common side effects include thrush, headache, and cough. [5] Serious side effects may include worsening asthma, anaphylaxis, seizures, and heart problems. [5]
Ads
related to: asthma inhaler prices